We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Home / About Novasep / Media & Events / Case studies

Case studies

Successful cGMP conjugation of a Novel ADC for phase I clinical trials

Successful cGMP conjugation of a Novel ADC for phase I clinical trials

15 Feb 2018

Novasep was approached by a top 10 pharmaceutical company to help with the manufacture of a cGMP antibody drug conjugate. The ADC was in clinical trial Phase I to treat solid tumors, and the customer required a quantity of ADC within 4 months starting from 100g monoclonal antibody.



You can stay on this page and select more documents or you can directly download the brochure(s) you selected
Give us your feedback!